Company Filing History:
2 out of 15 
1 out of 6 
1 out of 1,678 Years Active: 2010-2022
Title: Renate Schulze: Pioneering Innovations in Biotechnology
Introduction
Renate Schulze is an accomplished inventor hailing from Bensheim, Germany. With a remarkable portfolio of four patents, her work primarily focuses on advancements in biotechnology, particularly in the fields of molecular cloning and wound care.
Latest Patents
Among her latest innovations is a patented species of genus identified as BR11571, designated with the Accession Deposit Number DSM 32538. This invention showcases her dedication to enhancing biological research and applications. Furthermore, she developed a protease essential for wound conditioning and skin care, derived from the larvae of Lucilia sericata, known as debrilase. This particular protease is notable for its therapeutic efficacy in debridement of wounds. The patent describes a complex nucleic acid molecule encoding a serine protease with significant capabilities, detailing various nucleic acid sequences that exhibit high levels of identity to the original amino acid sequence.
Career Highlights
Renate has worked with notable organizations such as the Biotechnology Research and Information Network AG and Brain AG. Her contributions to these companies underscore her expertise and commitment to advancing biotechnological research and applications.
Collaborations
Throughout her career, Renate Schulze has collaborated with esteemed colleagues such as Jürgen Eck and Frank Niehaus. These partnerships highlight her integration into the scientific community and her proactive approach to innovation in her field.
Conclusion
Renate Schulze stands out as a significant figure in the realm of biotechnology. Her inventions not only exemplify her inventive spirit but also contribute to the ongoing advancement of medical and scientific knowledge. As she continues to innovate, her work will undoubtedly impact future generations in the field.